Identification of novel mutations in five patients with mitochondrial encephalomyopathy

Lucia Valente, Daniela Piga, Eleonora Lamantea, Franco Carrara, Graziella Uziel, Paola Cudia, Anna Zani, Laura Farina, Lucia Morandi, Marina Mora, Antonella Spinazzola, Massimo Zeviani, Valeria Tiranti

Research output: Contribution to journalArticle

Abstract

MELAS, MERRF, LHON and NARP, are well-established mitochondrial syndromes associated with specific point mutations of mitochondrial DNA (mtDNA). However, these recurrent mtDNA mutations account for only a minority of mitochondrial disease cases. To evaluate the impact of novel mtDNA mutations, we performed mtDNA sequence analysis in muscle and other tissues of 240 patients with different mitochondrial neuromuscular syndromes. We identified a total of 33 subjects with novel, private or uncommon mutations. Among these, five novel mutations were found in both paediatric and adult cases. We here report on the clinical description of these patients, as well as the biochemical and molecular genetic characterization of the corresponding mutations. Patients 1 and 2 showed changes in ND genes, patient 3 carried a heteroplasmic deletion in the COI gene, patients 4 and 5 carried heteroplasmic mutations in tRNATrp and tRNAPhe, respectively. Altogether, these data indicate that mtDNA analysis must become part of the routine screening for mitochondrial disorders.

Original languageEnglish
Pages (from-to)491-501
Number of pages11
JournalBiochimica et Biophysica Acta - Bioenergetics
Volume1787
Issue number5
DOIs
Publication statusPublished - May 2009

Fingerprint

Mitochondrial Encephalomyopathies
Mitochondrial DNA
Mutation
Mitochondrial Diseases
Genes
Molecular Biology
RNA, Transfer, Phe
MERRF Syndrome
MELAS Syndrome
Pediatrics
DNA sequences
Muscle
DNA Sequence Analysis
Screening
Point Mutation
Tissue
Muscles

Keywords

  • Mitochondrial DNA
  • mtDNA mutation
  • mtDNA Sequence analysis
  • Respiratory chain complex deficiency

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology

Cite this

Identification of novel mutations in five patients with mitochondrial encephalomyopathy. / Valente, Lucia; Piga, Daniela; Lamantea, Eleonora; Carrara, Franco; Uziel, Graziella; Cudia, Paola; Zani, Anna; Farina, Laura; Morandi, Lucia; Mora, Marina; Spinazzola, Antonella; Zeviani, Massimo; Tiranti, Valeria.

In: Biochimica et Biophysica Acta - Bioenergetics, Vol. 1787, No. 5, 05.2009, p. 491-501.

Research output: Contribution to journalArticle

Valente, Lucia ; Piga, Daniela ; Lamantea, Eleonora ; Carrara, Franco ; Uziel, Graziella ; Cudia, Paola ; Zani, Anna ; Farina, Laura ; Morandi, Lucia ; Mora, Marina ; Spinazzola, Antonella ; Zeviani, Massimo ; Tiranti, Valeria. / Identification of novel mutations in five patients with mitochondrial encephalomyopathy. In: Biochimica et Biophysica Acta - Bioenergetics. 2009 ; Vol. 1787, No. 5. pp. 491-501.
@article{9118ccb9e0b84ab28fb762df7908a7bf,
title = "Identification of novel mutations in five patients with mitochondrial encephalomyopathy",
abstract = "MELAS, MERRF, LHON and NARP, are well-established mitochondrial syndromes associated with specific point mutations of mitochondrial DNA (mtDNA). However, these recurrent mtDNA mutations account for only a minority of mitochondrial disease cases. To evaluate the impact of novel mtDNA mutations, we performed mtDNA sequence analysis in muscle and other tissues of 240 patients with different mitochondrial neuromuscular syndromes. We identified a total of 33 subjects with novel, private or uncommon mutations. Among these, five novel mutations were found in both paediatric and adult cases. We here report on the clinical description of these patients, as well as the biochemical and molecular genetic characterization of the corresponding mutations. Patients 1 and 2 showed changes in ND genes, patient 3 carried a heteroplasmic deletion in the COI gene, patients 4 and 5 carried heteroplasmic mutations in tRNATrp and tRNAPhe, respectively. Altogether, these data indicate that mtDNA analysis must become part of the routine screening for mitochondrial disorders.",
keywords = "Mitochondrial DNA, mtDNA mutation, mtDNA Sequence analysis, Respiratory chain complex deficiency",
author = "Lucia Valente and Daniela Piga and Eleonora Lamantea and Franco Carrara and Graziella Uziel and Paola Cudia and Anna Zani and Laura Farina and Lucia Morandi and Marina Mora and Antonella Spinazzola and Massimo Zeviani and Valeria Tiranti",
year = "2009",
month = "5",
doi = "10.1016/j.bbabio.2008.10.001",
language = "English",
volume = "1787",
pages = "491--501",
journal = "Biochimica et Biophysica Acta - Bioenergetics",
issn = "0005-2728",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Identification of novel mutations in five patients with mitochondrial encephalomyopathy

AU - Valente, Lucia

AU - Piga, Daniela

AU - Lamantea, Eleonora

AU - Carrara, Franco

AU - Uziel, Graziella

AU - Cudia, Paola

AU - Zani, Anna

AU - Farina, Laura

AU - Morandi, Lucia

AU - Mora, Marina

AU - Spinazzola, Antonella

AU - Zeviani, Massimo

AU - Tiranti, Valeria

PY - 2009/5

Y1 - 2009/5

N2 - MELAS, MERRF, LHON and NARP, are well-established mitochondrial syndromes associated with specific point mutations of mitochondrial DNA (mtDNA). However, these recurrent mtDNA mutations account for only a minority of mitochondrial disease cases. To evaluate the impact of novel mtDNA mutations, we performed mtDNA sequence analysis in muscle and other tissues of 240 patients with different mitochondrial neuromuscular syndromes. We identified a total of 33 subjects with novel, private or uncommon mutations. Among these, five novel mutations were found in both paediatric and adult cases. We here report on the clinical description of these patients, as well as the biochemical and molecular genetic characterization of the corresponding mutations. Patients 1 and 2 showed changes in ND genes, patient 3 carried a heteroplasmic deletion in the COI gene, patients 4 and 5 carried heteroplasmic mutations in tRNATrp and tRNAPhe, respectively. Altogether, these data indicate that mtDNA analysis must become part of the routine screening for mitochondrial disorders.

AB - MELAS, MERRF, LHON and NARP, are well-established mitochondrial syndromes associated with specific point mutations of mitochondrial DNA (mtDNA). However, these recurrent mtDNA mutations account for only a minority of mitochondrial disease cases. To evaluate the impact of novel mtDNA mutations, we performed mtDNA sequence analysis in muscle and other tissues of 240 patients with different mitochondrial neuromuscular syndromes. We identified a total of 33 subjects with novel, private or uncommon mutations. Among these, five novel mutations were found in both paediatric and adult cases. We here report on the clinical description of these patients, as well as the biochemical and molecular genetic characterization of the corresponding mutations. Patients 1 and 2 showed changes in ND genes, patient 3 carried a heteroplasmic deletion in the COI gene, patients 4 and 5 carried heteroplasmic mutations in tRNATrp and tRNAPhe, respectively. Altogether, these data indicate that mtDNA analysis must become part of the routine screening for mitochondrial disorders.

KW - Mitochondrial DNA

KW - mtDNA mutation

KW - mtDNA Sequence analysis

KW - Respiratory chain complex deficiency

UR - http://www.scopus.com/inward/record.url?scp=67349197091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349197091&partnerID=8YFLogxK

U2 - 10.1016/j.bbabio.2008.10.001

DO - 10.1016/j.bbabio.2008.10.001

M3 - Article

C2 - 18977334

AN - SCOPUS:67349197091

VL - 1787

SP - 491

EP - 501

JO - Biochimica et Biophysica Acta - Bioenergetics

JF - Biochimica et Biophysica Acta - Bioenergetics

SN - 0005-2728

IS - 5

ER -